Daniel A. Arber, M.D.

Publication Details

  • Detection of NPM/MLF1 fusion in t(3;5)-positive acute myeloid leukemia and myelodysplasia HUMAN PATHOLOGY Arber, D. A., Chang, K. L., Lyda, M. H., Bedell, V., Spielberger, R., Slovak, M. L. 2003; 34 (8): 809-813


    Balanced translocations are rare in myelodysplasia (MDS) and acute myeloid leukemia (AML) with multilineage dysplasia; however, the t(3;5)(q25;q35) and insertion variant occur in a subset of patients. To evaluate the possible genes involved in this translocation, we studied 6 cases with a t(3;5) by fluorescence in situ hybridization with probes directed against the nucleophosmin (NPM), EVI1, and Ribophorin genes, as well as a newly developed myeloid leukemia factor 1 (MLF1) BAC clone. The histologic spectrum of the cases was variable, ranging from refractory cytopenia with multilineage dysplasia to AML with multilineage dysplasia in the World Health Organization classification. An NPM/MLF1 fusion was identified in 5 of 6 cases, whereas the EVI1 and Ribophorin genes were not involved in any of the cases. The NPM/MLF1-positive cases were predominantly young adult males (median age, 33 years) who responded well to hematopoietic stem cell transplantation. These findings suggest that an NPM/MLF1 fusion is the primary molecular abnormality in t(3;5) MDS and AML with multilineage dysplasia, and also that cases with NPM/MLF1 may be clinically distinct from other MDS-associated disease.

    View details for DOI 10.1016/S0046-8177(03)00251-X

    View details for Web of Science ID 000184992200014

    View details for PubMedID 14506644

Stanford Medicine Resources:

Footer Links: